WhitTier Trust Company’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54K Sell
7
-6
-46% -$1.24K ﹤0.01% 1317
2026
Q1
$2.92K Buy
13
+6
+86% +$1.5K ﹤0.01% 1224
2025
Q4
$1.74K Hold
7
﹤0.01% 1181
2025
Q3
$1.95K Hold
7
﹤0.01% 1179
2025
Q2
$1.81K Sell
7
-1
-13% -$239 ﹤0.01% 1318
2025
Q1
$1.79K Sell
8
-101
-93% -$23.6K ﹤0.01% 1297
2024
Q4
$24.9K Hold
109
﹤0.01% 892
2024
Q3
$26.6K Hold
109
﹤0.01% 885
2024
Q2
$20.9K Hold
109
﹤0.01% 882
2024
Q1
$21.6K Hold
109
﹤0.01% 838
2023
Q4
$18.8K Buy
109
+6
+6% +$922 ﹤0.01% 855
2023
Q3
$15.2K Buy
103
+1
+1% +$181 ﹤0.01% 866
2023
Q2
$22.3K Hold
102
﹤0.01% 840
2023
Q1
$22.3K Hold
102
﹤0.01% 825
2022
Q4
$21.2K Hold
102
﹤0.01% 834
2022
Q3
$22K Hold
102
﹤0.01% 801
2022
Q2
$21K Hold
102
﹤0.01% 810
2022
Q1
$25K Hold
102
﹤0.01% 777
2021
Q4
$27K Hold
102
﹤0.01% 763
2021
Q3
$27K Hold
102
﹤0.01% 778
2021
Q2
$25K Hold
102
﹤0.01% 758
2021
Q1
$20K Hold
102
﹤0.01% 776
2020
Q4
$22K Hold
102
﹤0.01% 745
2020
Q3
$17K Hold
102
﹤0.01% 758
2020
Q2
$20K Hold
102
﹤0.01% 722
2020
Q1
$15K Hold
102
﹤0.01% 739
2019
Q4
$16K Hold
102
﹤0.01% 781
2019
Q3
$14K Buy
+102
New +$13.4K ﹤0.01% 783

Other funds holding RMD

WhitTier Trust Company's RMD Position: Q2 2026 in Review

WhitTier Trust Company reduced its ResMed (RMD) stake by 46% in Q2 2026, selling an estimated $1.24K and leaving 7 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1317.

WhitTier Trust Company first reported a position in RMD in Q3 2019 and has held it in 28 quarters since. The position peaked at $27K in Q4 2021. 406 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • WhitTier Trust Company held 7 shares of ResMed worth $1.54K as of Q2 2026.
  • WhitTier Trust Company sold 6 ResMed shares in Q2 2026, an estimated $1.24K.
  • ResMed made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1317 holding.
  • WhitTier Trust Company first reported a position in ResMed in Q3 2019 and has held it in 28 quarters since.
  • WhitTier Trust Company's ResMed position peaked at $27K in Q4 2021.
  • 406 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.